224 related articles for article (PubMed ID: 18211945)
1. Methylation of CpG island promoters in uveal melanoma.
Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of RASSF1a in uveal melanoma.
Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
[TBL] [Abstract][Full Text] [Related]
4. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation.
Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
J Pathol; 2006 Jan; 208(1):100-7. PubMed ID: 16278815
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Liu S; Ren S; Howell P; Fodstad O; Riker AI
Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
[TBL] [Abstract][Full Text] [Related]
6. Expression of p16 in sporadic primary uveal melanoma.
Lamperska K; Mackiewicz K; Kaczmarek A; Kwiatkowska E; Starzycka M; Romanowska B; Heizman J; Stachura J; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):377-85. PubMed ID: 12362979
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
[TBL] [Abstract][Full Text] [Related]
10. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
Bello MJ; De Campos JM; Isla A; Casartelli C; Rey JA
Oncol Rep; 2006 Feb; 15(2):443-8. PubMed ID: 16391867
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
[TBL] [Abstract][Full Text] [Related]
12. Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.
Dammann R; Schagdarsurengin U; Seidel C; Trümpler C; Hoang-Vu C; Gimm O; Dralle H; Pfeifer GP; Brauckhoff M
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):1-7. PubMed ID: 15662588
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
[TBL] [Abstract][Full Text] [Related]
15. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa.
Iacopetta B; Grieu F; Phillips M; Ruszkiewicz A; Moore J; Minamoto T; Kawakami K
Cancer Sci; 2007 Sep; 98(9):1454-60. PubMed ID: 17640302
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
17. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
[TBL] [Abstract][Full Text] [Related]
18. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma.
Ksiaa F; Ziadi S; Amara K; Korbi S; Trimeche M
Clin Chim Acta; 2009 Jun; 404(2):128-33. PubMed ID: 19336228
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]